Search PubMed⌕ Search

Biomedical subjects

W Storch

Publications and source records attributed to W Storch.

At least 19 recordsLinked to original sources

[Virus and autoimmunity with emphasis on liver diseases].

The dualism virus pathogenesis and autoimmune pathogenesis in liver disease is given up increasingly. A survey is given about the development of autoimmunity and virus induction of the autoimmune hepatitis. The hypothesis of virus induction of autoimmune hepatitis put forward by Storch 1975 (19) is unproven up to now, but the concept of virus-associated autoimmune hepatitis put forward by Storch 1980 (23) is acknowledged today. First of all, antibodies against endoplasmic reticulum (liver and kidney microsomes) type 1, liver ribosomes, and liver cell cytoplasm are regarded as markers of a hepatitis C virus-associated autoimmune hepatitis. At present it is unknown, if antibodies against the surface of tongue epithelium, basal cells of squamous epithelium, Golgi apparatus, and nerve cells are further suitable markers.

Autoantigens↗

[Ulcerative colitis and Crohn disease from the immunologic viewpoint].

A critical immunological survey is given on etiology and pathogenesis of ulcerative colitis and Crohn's disease. Since antigen specific suppressor cells are presumably not very likely, the appropriate hypotheses must be replaced by new ones. Assuming disturbances of the regulation of the immune system as the key to etiopathogenesis, a genetic hypothesis can be presented. This hypothesis is based on the assumption of physiological and pathogenic autogenes as well as regulator genes.

Autoantigens↗

[Virus and autoimmune disease. An excursion exemplified by autoimmune hepatitis].

At least since the discovery of the acquired immune deficiency syndrome and the "human immune deficiency virus" (HIV) it has been widely accepted, that viruses infect lymphocytes (mainly especially CD 4 positive helper lymphocytes) and can also be responsible for their deletion. However, since the HIV can only be found in a small proportion of the dying lymphocytes, other viruses as well as other (nonviral) cytotoxic agents and mechanisms must be taken into consideration. The conception of involved autoimmune phenomena is being accepted increasingly. Storch's hypothesis put forward in 1975, of primary or secondary viral infection of lymphocytes as pathogenetical principle of autoimmune hepatitis (infected B- and T-lymphocytes stimulate directly or indirectly the antibody synthesis and also trigger abnormal cellular immune reactions) was confirmed. Teleologically regarded, in most cases it remains open if the demonstrable autoantibodies and immune cells are pathogenic, protective, or indifferent for the individual. Analogous to symbiosis and parasitism, this postulate can be extended to pathogenic viral infections. Assuming that the human organism is anxious to remain unharmed and, like viruses maintain its adaptability by a system of multiform control systems one can imagine, that the autoimmunity induced by and therefore directed primarily against viruses can be regarded as "physiological", thus representing a protective mechanism against disturbing exogenous and endogenous factors. It can be considered part of the "prophylaxien" (Holle, 1989). Likewise, in autoimmune hepatitis as well, new findings speak for a participation of several (various) viruses in its aetiopathogenesis. It is hypothesized, that so-called "autogenes" exist which lead to autoimmune disease (like oncogenes involved in the pathogenesis of malignancies).

Autoantibodies↗

[Dermatomyositis--pathogenesis, diagnosis, therapy].

Dermatomyositis is a rare systemic autoimmune disease that principally involves the skeletal muscles. Currently, the etiopathology is suspected to involve a viral infection with underlying genetic susceptibility, resulting in an abnormal immune reaction. Autoantibodies, in particular against enzymes involved in protein synthesis--especially aminoacyl-tRNA synthetases--appear to be found for the most part when the lungs are involved. Differential diagnosis is facilitated by the detection of various auto-antibodies. Treatment is unsatisfactory, and controlled studies, in particular when resistance to prednisone presents, are lacking. The prognosis depends, among other things, on the internal organs involved (heart, lungs, gastrointestinal tract, endocrine system). The search for viruses (e.g. hepatitis B) should be intensified using the latest, more sensitive, methods.

Autoantibodies↗

[Antibodies against D-penicillamine in primary biliary cirrhosis].

25 serum samples of 22 patients with primary biliary cirrhosis (15 under or after treatment with D-penicillamine) were tested for antibodies against D-penicillamine. Complement-binding IgG-antibodies demonstrated by a 4 layer immunofluorescence test were found only in 3 patients with suggested D-penicillamine allergy. These findings suggest a causal relation between penicillamine antibodies and penicillamine-induced side effects.

Drug Hypersensitivity↗

[Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].

Antibodies to D-penicillamine (DPA) were determined in 25 patients with classic rheumatoid arthritis being treated with DPA. Positive results were found before and during therapy with DPA. Antibodies were found in seven out of ten patients without the desired therapeutic effects; in five cases before starting the therapy. It is hypothesized that antibodies against drugs are heterogeneous and influence the effect of the drugs, e.g. inhibition of the desired effect and stimulation of an undesired (adverse) reaction.

Adult↗

[The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].

121 serum samples from 54 patients with Wilson's disease were tested for antibodies against D-penicillamine by indirect immunofluorescence (DASS-system). IgG antibodies were found in 44 serum samples from 16 patients (31% of all patients). The incidence of serum antibodies was higher in patients with side effects during therapy with D-penicillamine (10 of 13 patients 77%) compared to 6 of 39 15% in patients without side effects. The titre of antibodies was higher in patients with side effects. The antibodies bound complement demonstrated by double immunofluorescence. These observations indicate that complement binding IgG antibodies to D-penicillamine are involved in pathogenesis of side effects during therapy with D-penicillamine.

Antibodies↗

[Virus-associated chronic autoimmune aggressive hepatitis (HBsAg seronegative) with pronounced diarrhea].

It is reported on a 17-year-old male patient who in 1982 fell ill with a HBsAg-seronegative hepatitis with therapy-resistant diarrhoeas of high frequency and in whom immunohistologically a virus-associated autoimmune chronic aggressive hepatitis was established. As cause of severe diarrhoeas which underwent involution only after 2 months as a sequel of the azathioprin-prednisolone therapy the proof of HBsAg in Lieberkühn's crypts of the small intestine performed by means of direct immunofluorescence is assumed.

Adolescent↗

Immunohistological investigations of PAS-negative globular intracisternal hyalin in human liver biopsy specimens.

Eight liver biopsy specimens from five patients with PAS-negative intracisternal hyalin were investigated by immunofluorescence for: (1) immunoglobulins (Ig) G, A, M, D, E; (2) light chains (kappa and lambda); (3) complement components C1q, C4, C3c, C5, C9; (4) C1-inactivator; (5) C3-activator; (6) alpha 1-antitrypsin; (7) alpha 1-antichymotrypsin; (8) plasminogen; (9) fibrinogen; (10) fibrinogen breakdown products D and E; (11) fibronectin; (12) prealbumin; (13) albumin; (14) betalipoprotein; (15) apolipoprotein; (16) alpha 1- and alpha 2-glycoprotein; (17) cholinesterase; (18) ceruloplasmin; (19) haemopexin; (20) myoglobin; (21) placenta lactogen; (22) transferrin; (23) actin; (24) myosin; (25) cathepsin D; and (26) hepatitis B surface and core antigens (HBsAg and HBcAg). The globules reacted significantly with antisera against C3c (three patients), C4 (three patients), C3-activator (one patient) and fibrinogen (two patients). The cause of the protein accumulation is not clear. Serial studies indicate the possibility of a disturbance of protein secretion and an as yet unidentified immune complex disorder.

Complement C3↗

[The detection of antibodies against D-penicillamine. 1. Coupling of D-penicillamine to various carriers and generation of antibodies against D-penicillamine conjugate].

D-Penicillamin as 2-substituted 5,5-Dimethyl-thiazolidine-4-carbonic acid has been bound to poly-L-lysin, human serum albumin and bovine gamma globulin by means of a water-soluble carbodiimid. The anti-bodies generated at animal tests by immunization of guinea pigs had been proved by means of the radial immune diffusion acc. to Ouchterlony [10].

Animals↗

[Detection of antibodies against D-penicillamine. 2. Experimental animal proof of production of antibodies against D-penicillamine using indirect immunofluorescence with a DASS system].

Antibodies against D-penicillamine conjugates produced in animals be proved by indirect immunofluorescence by means of the DASS system (defined antigen substrate spheres). The artificial substrate (Sephadex G-25) has not been bound to the D-penicillamine conjugates used for immunization, but only to D-penicillamine, which justifies the assumption that antibodies against D-penicillamine could be registered and proved by the immunofluorescence test mentioned.

Animals↗